Patents by Inventor Tim Hoey

Tim Hoey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190060453
    Abstract: An isolated antibody that specifically binds to an extracellular domain of human DLL4 and affects growth of a tumor comprising cancer stem cells is described. Also described is a method of treating cancer comprising administering a therapeutically effective amount of an anti-DLL4 antibody.
    Type: Application
    Filed: August 24, 2018
    Publication date: February 28, 2019
    Inventors: Austin GURNEY, Fumiko AXELROD, Tim HOEY, Sanjeev SATYAL
  • Publication number: 20160367667
    Abstract: An isolated antibody that specifically binds to an extracellular domain of human DLL4 and affects growth of a tumor comprising cancer stem cells is described. Also described is a method of treating cancer comprising administering a therapeutically effective amount of an anti-DLL4 antibody.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 22, 2016
    Inventors: Austin GURNEY, Fumiko AXELROD, Tim HOEY, Sanjeev SATYAL
  • Patent number: 9376497
    Abstract: An isolated antibody that specifically binds to an extracellular domain of human DLL4 and affects growth of a tumor comprising cancer stem cells is described. Also described is a method of treating cancer comprising administering a therapeutically effective amount of an anti-DLL4 antibody.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: June 28, 2016
    Assignee: ONCOMED PHARMACEUTICALS, INC.
    Inventors: Austin Gurney, Fumiko Axelrod, Tim Hoey, Sanjeev Satyal
  • Publication number: 20140030786
    Abstract: The present invention relates to compositions and methods for characterizing, treating and diagnosing cancer. In particular, the present invention provides a cancer stem cell profile, as well as novel stem cell cancer markers useful for the diagnosis, characterization, prognosis and treatment of cancer and in particular the targeting of solid tumor stem cells.
    Type: Application
    Filed: July 11, 2013
    Publication date: January 30, 2014
    Applicant: The Regents of the University of Michigan
    Inventors: Michael F. Clarke, Tim Hoey, Xinhao Wang, Scott Dylla, Austin Gurney, Piero Dalerba, Grace Chen, Mark Prince
  • Publication number: 20100316637
    Abstract: An isolated antibody that specifically binds to an extracellular domain of human DLL4 and affects growth of a tumor comprising cancer stem cells is described. Also described is a method of treating cancer comprising administering a therapeutically effective amount of an anti-DLL4 antibody.
    Type: Application
    Filed: May 18, 2010
    Publication date: December 16, 2010
    Applicant: ONCOMED PHARMACEUTICALS, INC.
    Inventors: AUSTIN GURNEY, FUMIKO AXELROD, TIM HOEY, SANJEEV SATYAL
  • Patent number: 7750124
    Abstract: An isolated antibody that specifically binds to an extracellular domain of human DLL4 and affects growth of a tumor comprising cancer stem cells is described. Also described is a method of treating cancer comprising administering a therapeutically effective amount of an anti-DLL4 antibody.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: July 6, 2010
    Assignee: OncoMed Pharmaceuticals, Inc.
    Inventors: Austin Gurney, Fumiko Axelrod, Tim Hoey, Sanjeev Satyal
  • Publication number: 20100169990
    Abstract: The present invention relates to compositions and methods for characterizing, treating and diagnosing cancer. In particular, the present invention provides a cancer stem cell profile, as well as novel stem cell cancer markers useful for the diagnosis, characterization, prognosis and treatment of cancer and in particular the targeting of solid tumor stem cells.
    Type: Application
    Filed: December 31, 2009
    Publication date: July 1, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Michael F. Clarke, Tim Hoey, Xinhao Wang, Scott Dylla, Austin Gurney, Piero Dalerba, Grace Chen, Mark Prince
  • Patent number: 7723112
    Abstract: The present invention relates to compositions and methods for characterizing, treating and diagnosing cancer. In particular, the present invention provides a cancer stem cell profile, as well as novel stem cell cancer markers useful for the diagnosis, characterization, prognosis and treatment of cancer and in particular the targeting of solid tumor stem cells.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: May 25, 2010
    Assignees: The Regents of the University of Michigan, OncoMed Pharmaceuticals, Inc.
    Inventors: Michael F. Clarke, Tim Hoey, Xinhao Wang, Scott Dylla, Austin Gurney, Piero Dalerba, Mark Prince, Grace Chen
  • Publication number: 20080187532
    Abstract: An isolated antibody that specifically binds to an extracellular domain of human DLL4 and affects growth of a tumor comprising cancer stem cells is described. Also described is a method of treating cancer comprising administering a therapeutically effective amount of an anti-DLL4 antibody.
    Type: Application
    Filed: September 28, 2007
    Publication date: August 7, 2008
    Inventors: Austin Gurney, Fumiko Axelrod, Tim Hoey, Sanjeev Satyal
  • Publication number: 20080064049
    Abstract: The present invention relates to compositions and methods for characterizing, treating and diagnosing cancer. In particular, the present invention provides a cancer stem cell profile, as well as novel stem cell cancer markers useful for the diagnosis, characterization, prognosis and treatment of cancer and in particular the targeting of solid tumor stem cells.
    Type: Application
    Filed: October 31, 2006
    Publication date: March 13, 2008
    Inventors: Michael Clarke, Tim Hoey, Xinhao Wang, Scott Dylla, Austin Gumey, Pierro Dalerba, Grace Chen, Mark Prince